Trial
NCT00940095
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Idorsia Pharmaceuticals Ltd.
Collaborators
—
Condition
Aneurysmal Subarachnoid Hemorrhage
Intervention
Clazosentan 5 m/h
Why stopped
Lack of efficacy data from the Phase 3 clinical study (AC-054-301; CONSCIOUS-2)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-09